Volume 31, Issue 3-4

Search all Cancer and Metastasis Reviews articles

December 2012

Special Issue: Metastasis Genes

Issue Editors:

Danny R. Welch,
Yibin Kang

37 articles in this issue

Biographies

Announcement 14 October 2012 Pages: 415 - 416
Preface
Danny R. Welch
EditorialNotes 14 June 2012 Pages: 417 - 418
Genomics screens for metastasis genes
Jinchun Yan
Qihong Huang
OriginalPaper 09 June 2012 Pages: 419 - 428
The metastatic niche and stromal progression
Jonathan P. Sleeman
OriginalPaper Open access 15 June 2012 Pages: 429 - 440
Diet, nutrients, phytochemicals, and cancer metastasis suppressor genes
Gary G. Meadows
OriginalPaper 13 June 2012 Pages: 441 - 454
The rejuvenated scenario of epithelial–mesenchymal transition (EMT) and cancer metastasis
Fanyan Meng
Guojun Wu
OriginalPaper 26 June 2012 Pages: 455 - 467
Mesenchymal–epithelial transition (MET) as a mechanism for metastatic colonisation in breast cancer
N. P. A. Devika Gunasinghe
Alan Wells
Honor J. Hugo
OriginalPaper 23 June 2012 Pages: 469 - 478
Growth factor signaling in metastasis: current understanding and future opportunities
Frank J. Lowery
Dihua Yu
OriginalPaper 17 June 2012 Pages: 479 - 491
Suppression of tumor and metastasis progression through the scaffolding functions of SSeCKS/Gravin/AKAP12
Irwin H. Gelman
OriginalPaper 09 June 2012 Pages: 493 - 500
Regulation of the metastatic cell phenotype by sialylated glycans
Matthew J. Schultz
Amanda F. Swindall
Susan L. Bellis
OriginalPaper 15 June 2012 Pages: 501 - 518
The faces and friends of RhoGDI2
Erin M. Griner
Dan Theodorescu
OriginalPaper 21 June 2012 Pages: 519 - 528
Maspin: molecular mechanisms and therapeutic implications
Thomas M. Bodenstine
Richard E. B. Seftor
Mary J. C. Hendrix
OriginalPaper 01 July 2012 Pages: 529 - 551
TGF-β signalling and its role in cancer progression and metastasis
Yvette Drabsch
Peter ten Dijke
OriginalPaper 20 June 2012 Pages: 553 - 568
Genes associate with abnormal bone cell activity in bone metastasis
G. David Roodman
OriginalPaper 17 June 2012 Pages: 569 - 578
Mouse models of breast cancer metastasis to bone
Kelsi L. Kretschmann
Alana L. Welm
OriginalPaper 16 June 2012 Pages: 579 - 583
KiSS1 and its G-protein-coupled receptor GPR54 in cancer development and metastasis
Sung-Gook Cho
Dali Li
Mingyao Liu
OriginalPaper 13 June 2012 Pages: 585 - 591
Insights into the biology and prevention of tumor metastasis provided by the Nm23 metastasis suppressor gene
Natascia Marino
Joji Nakayama
Patricia S. Steeg
OriginalPaper 16 June 2012 Pages: 593 - 603
Using MKK4’s metastasis suppressor function to identify and dissect cancer cell–microenvironment interactions during metastatic colonization
Venkatesh Krishnan
Nathan Stadick
Carrie Rinker-Schaeffer
OriginalPaper 17 June 2012 Pages: 605 - 613
Raf kinase inhibitor protein (RKIP) in cancer
June Escara-Wilke
Kam Yeung
Evan T. Keller
OriginalPaper 09 June 2012 Pages: 615 - 620
Driving transcriptional regulators in melanoma metastasis
Aaron K. Mobley
Russell R. Braeuer
Menashe Bar-Eli
OriginalPaper 09 June 2012 Pages: 621 - 632
MDM2 binding protein, a novel metastasis suppressor
Tomoo Iwakuma
Neeraj Agarwal
OriginalPaper 10 June 2012 Pages: 633 - 640
Metastasis suppression by BRMS1 associated with SIN3 chromatin remodeling complexes
Douglas R. Hurst
OriginalPaper 08 June 2012 Pages: 641 - 651
MicroRNA control of epithelial–mesenchymal transition and metastasis
Jinsong Zhang
Li Ma
OriginalPaper 09 June 2012 Pages: 653 - 662
Molecular characterization of circulating tumor cells in breast cancer: challenges and promises for individualized cancer treatment
Evi S. Lianidou
Athina Markou
Areti Strati
OriginalPaper 13 June 2012 Pages: 663 - 671
Plasticity of disseminating cancer cells in patients with epithelial malignancies
Natalia Bednarz-Knoll
Catherine Alix-Panabières
Klaus Pantel
OriginalPaper 26 June 2012 Pages: 673 - 687
Non-glucose metabolism in cancer cells—is it all in the fat?
Swethajit Biswas
John Lunec
Kim Bartlett
OriginalPaper 17 June 2012 Pages: 689 - 698
Pharmacological strategies to spare normal tissues from radiation damage: useless or overlooked therapeutics?
Céline Bourgier
Antonin Levy
Eric Deutsch
Non-Thematic Review 16 June 2012 Pages: 699 - 712
Ovarian cancer molecular pathology
Rémi Longuespée
C. Boyon
Michel Salzet
NON-THEMATIC REVIEW 23 June 2012 Pages: 713 - 732
Cancer stem cells, microRNAs, and therapeutic strategies including natural products
Darshni Vira
Saroj K. Basak
Eri S. Srivatsan
NON-THEMATIC REVIEW 01 July 2012 Pages: 733 - 751
EZH2 inhibition: targeting the crossroad of tumor invasion and angiogenesis
Francesco Crea
Lorenzo Fornaro
Romano Danesi
NON-THEMATIC REVIEW 19 June 2012 Pages: 753 - 761
Galectin-1 as a potent target for cancer therapy: role in the tumor microenvironment
Koichi Ito
Kimberley Stannard
Stephen J. Ralph
NON-THEMATIC REVIEW 17 June 2012 Pages: 763 - 778
Role of the EpCAM (CD326) in prostate cancer metastasis and progression
Jie Ni
Paul J. Cozzi
Yong Li
NON-THEMATIC REVIEW 21 June 2012 Pages: 779 - 791
Transcription factor PROX1: its role in development and cancer
Tamador Elsir
Anja Smits
Monica Nistér
NON-THEMATIC REVIEW 26 June 2012 Pages: 793 - 805
Acquired resistance mechanisms to tyrosine kinase inhibitors in lung cancer with activating epidermal growth factor receptor mutation—diversity, ductility, and destiny
Kenichi Suda
Hiroshi Mizuuchi
Tetsuya Mitsudomi
NON-THEMATIC REVIEW 27 June 2012 Pages: 807 - 814
Metastatic view of breast cancer
Gaspar Banfalvi
NON-THEMATIC REVIEW 06 July 2012 Pages: 815 - 822
The impact of tumor microenvironment on cancer treatment and its modulation by direct and indirect antivascular strategies
Emmanouil Fokas
W. Gillies McKenna
Ruth J. Muschel
NON-THEMATIC REVIEW 24 July 2012 Pages: 823 - 842
The role of FOXP3 in the development and metastatic spread of breast cancer
Stephen Douglass
Simi Ali
John A. Kirby
NON-THEMATIC REVIEW 26 July 2012 Pages: 843 - 854

Volume 31, Issue 3-4

Search

Navigation